During the thirteen weeks ended March 31, 2024 and March 26, 2023, the rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock were identical, except with respect to voting. As the liquidation and dividend rights were identical, the undistributed earnings were allocated on a

proportionate basis and the resulting net loss per share attributable to common stockholders were, therefore, the same for both Class A and Class B common stock on an individual or combined basis.


	Thirteen weeks ended
	March 31, 2024		March 26, 2023
(dollar amounts in thousands)
Numerator:
Net loss	$	(26,067)	$	(33,657)
Denominator:
Weighted-average common shares outstanding—basic and diluted	112,772,776		111,297,064
Earnings per share—basic and diluted	$	(0.23)	$	(0.30)

The Company’s potentially dilutive securities, which include preferred stock, time-based vesting restricted stock units, performance stock units, contingently issuable stock and options to purchase common stock, have been excluded from the computation of diluted net loss per share as the effect would be antidilutive. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:


	Thirteen weeks ended
	March 31, 2024	March 26, 2023
Options to purchase common stock	14,569,140	14,367,322

Time-based vesting restricted stock units	1,177,911	1,610,403
Performance stock units	6,300,000	6,621,428
Contingently issuable stock	506,243	714,285
Total common stock equivalents	22,553,294	23,313,438